Skip to content

Clinical trials

Phase 3 Inflammatory Bowel Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Phase: Phase 3 Country / region: France Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20091
20102
20116
20122
20151
20161
20183
20212
20231
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated6
Active, not recruiting3
Recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC5
Assistance Publique - Hôpitaux de Paris3
Eli Lilly and Company3
GlaxoSmithKline2
InDex Pharmaceuticals2
University Hospital, Grenoble2
CMC Ambroise Paré1
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives1
Janssen Biotech, Inc.1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases24
Crohn Disease14
Colitis, Ulcerative10
Colitis3
Anemia2
Gastrointestinal Diseases2
Anemia, Iron-Deficiency1
Cytomegalovirus Infections1
Deficiency Diseases1
Fistula1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.